Access cutting-edge cirrhosis treatment through this clinical trial at a research site in Birmingham. Study-provided care at no cost to qualified participants.
Access cirrhosis specialists in Birmingham at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cirrhosis treatment provided free
This is a multi-center evaluation of efruxifermin (EFX) in a randomized, double-blind, placebo-controlled study in subjects with compensated cirrhosis due to NASH/MASH.
Sponsor: Akero Therapeutics, Inc
Check if you qualify for this cirrhosis clinical trial in Birmingham, AL
If you're searching for cirrhosis treatment options in Birmingham, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Birmingham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cirrhosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.